Table 1. Npl3 phosphorylation sites.
Npl3 (414 aa) | Phosphorylated Serines | Treatment | Analysis | Reference |
Endogenous | Ser212, | WCE (whole cell extract) | MS | This study |
Ser224 | WCE | MS-IMAC | This study, [34] | |
Ser349, Ser356 | WCE | MS-IMAC | (Ficarro et al, 2002) | |
Ser411 | 32P-in vivo labeling | 2D gel | (Gilbert et al, 2001) | |
CK2 in vitro phosphorylated | Ser77, Ser79, | Kinase assay | MS | This study |
Ser212, Ser230, | “ | |||
Ser328, Ser336, | “ | |||
Ser349, Ser356 | “ | |||
Ser411 | Point mutants |
Phosphorylation sites identified in Npl3.
Highlighted residues where phosphorylation sites detected in both the endogenous and in vitro CK2 phosphorylated Npl3.